Merck KGaA is experiencing growth driven by strong demand in both its semiconductor and pharmaceutical divisions. This analysis examines the factors contributing to this growth and its implications for the company's fut…
Analyst insights suggest Glenmark Pharma, Alkem Labs, and Syrma SGS are stocks to monitor. Market dynamics and company-specific developments influence their potential performance. Investors should conduct thorough resea…
The Invesco QQQ ETF, tracking the Nasdaq-100, is currently navigating record highs. This analysis examines the ETF's composition, performance drivers, and potential risks amid market volatility. Understanding these fact…
GoodRx anticipates significant changes in prescription savings due to the introduction of TrumpRx. The potential impact on market dynamics and consumer access to affordable medications is currently being evaluated by in…
Midwest Pharma has announced its IPO price band, set between ₹1,014 and ₹1,065 per share. The IPO represents a significant milestone for the company as it seeks to expand its operations and market presence.